Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF‑7 cells

Wang,Ruxing; Lu,Yanjie; Li,Hong; Sun,Lixin; Yang,Ning; Zhao,Mingzhen; Zhang,Manli; Shi,Qingwen

doi:10.3892/ol.2018.8039

Antitumor activity of the Ailanthus altissima bark phytochemical ailanthone against breast cancer MCF‑7 cells

Authors:
- Ruxing Wang
- Yanjie Lu
- Hong Li
- Lixin Sun
- Ning Yang
- Mingzhen Zhao
- Manli Zhang
- Qingwen Shi
View Affiliations

Affiliations: Department of Medicinal Natural Product Chemistry, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Department of Pathology, Institute of Cancer Research, Chengde Medical College, Chengde, Hebei 067000, P.R. China, Department of Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, Hebei 067000, P.R. China
Published online on: February 13, 2018 https://doi.org/10.3892/ol.2018.8039
Pages: 6022-6028

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Ailanthone is isolated from the bark of Ailanthus altissima (Mill.) Swingle (Simaroubaceae). The mechanism that underlies the activity of ailanthone on MCF‑7 cells was investigated by MTT assay. Breast cancer MCF‑7 cells were treated with 0.5, 1.0, 2.0, 4.0 and 8.0 µg/ml ailanthone for 24, 48 and 72 h. The inhibition of proliferation induced by treatment with ailanthone was assessed by MTT assay. Apoptosis and cell cycle distribution in MCF‑7 cells with the same doses of ailanthone for 48 h were determined by flow cytometry. Expression of apoptosis‑associated genes and proteins were analyzed by reverse transcription‑polymerase chain reaction (RT‑PCR) and western blot analysis, respectively. The results revealed that ailanthone inhibited MCF‑7 cell proliferation. Flow cytometry assay demonstrated that ailanthone induced apoptosis and G0/G1 cell cycle arrest in MCF‑7 cells. Western blotting and RT‑PCR assays demonstrated that upregulation of pro‑apoptotic caspase‑3 and Bcl‑associated X, and downregulation of anti‑apoptotic apoptosis regulator B‑cell lymphoma‑2 in MCF‑7 cells may be associated with the induction of apoptosis and inhibition of proliferation. To the best of our knowledge, the present study is the first to investigate the antitumor activity of ailanthone from A. altissima on MCF‑7 cells and to attempt to elucidate the underlying mechanism. The present study revealed the presence of ailanthone‑mediated antitumor effects, indicating that ailanthone may be a novel phytomedicine with potential use in breast cancer therapy.

View Figures

View References

1	Khoobchandani M, Ojeswi BK, Sharma B and Srivastava MM: Chenopodium album prevents progression of cell growth and enhances cell toxicity in human breast cancer cell lines. Oxid Med Cell Longev. 2:160–165. 2009. View Article : Google Scholar : PubMed/NCBI
2	Tokgun O, Akca H, Mammadov R, Aykurt C and Deniz G: Convolvulus galaticus, crocus antalyensis, and lilium candidum extracts show their antitumor activity through induction of p53-mediated apoptosis on human breast cancer cell line MCF-7 Cells. J Med Food. 11:1000–1005. 2012. View Article : Google Scholar
3	Binkley JM, Harris SR, Levangie PK, Pearl M, Guglielmino J, Kraus V and Rowden D: Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer. Cancer. 8:2207–2216. 2012. View Article : Google Scholar
4	Sitzia J and Huggins L: Side effects of cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) chemotherapy for breast cancer. Cancer Pract. 6:13–21. 1998. View Article : Google Scholar : PubMed/NCBI
5	da Rocha AB, Lopes RM and Schwartsmann G: Natural products in anticancer therapy. Curr Opin Pharmacol. 1:364–369. 2001. View Article : Google Scholar : PubMed/NCBI
6	Efferth T, Li PC, Konkimalla VS and Kaina B: From traditional Chinese medicine to rational cancer therapy. Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
7	Olaku O and White JD: Herbal therapy use by cancer patients: A literature review on case reports. Eur J Cancer. 47:508–514. 2011. View Article : Google Scholar : PubMed/NCBI
8	Dennis T, Fanous M and Mousa S: Natural products for chemopreventive and adjunctive therapy in oncologic disease. Nutr Cancer. 61:587–597. 2009. View Article : Google Scholar : PubMed/NCBI
9	Ho JW, Leung YK and Chan CP: Herbal medicine in the treatment of cancer. Curr Med Chem Anticancer Agents. 2:209–214. 2002. View Article : Google Scholar : PubMed/NCBI
10	Pezzuto JM: Plant-derived anticancer agents. Biochem Pharmacol. 53:121–133. 1997. View Article : Google Scholar : PubMed/NCBI
11	Kinghorn AD, Farnsworth NR, Doel Soejarto D, Cordell GA, Pezzuto JM, Udeani GO, Wani MC, Wall ME, Navarro HA, Kramer RA, et al: Novel strategies for the discovery of plant-derived anticancer agents. Pure Appl Chem. 71:611–618. 1999. View Article : Google Scholar
12	Lee KH: Anticancer drug design based on plant-derived natural products. J Biomed Sci. 6:236–250. 1999. View Article : Google Scholar : PubMed/NCBI
13	Bishayee A: Editorial: Current advances in cancer prevention and treatment by natural products. Curr Pharm Biotechnol. 13:115–116. 2012. View Article : Google Scholar : PubMed/NCBI
14	Efferth T, Li PC, Konkimalla VS and Kaina B: From traditional Chinese edicine to rational cancer therapy. Trends Mol Med. 13:353–361. 2007. View Article : Google Scholar : PubMed/NCBI
15	De Feo V, De Martino L, Quaranta E and Pizza C: Isolation of phytotoxic compounds from tree-of-heaven (Ailanthus altissima swingle). J Agric Food Chem. 51:1177–1180. 2003. View Article : Google Scholar : PubMed/NCBI
16	Rahman S, Fukamiya N, Ohno N, Tokuda H, Nishino H, Tagahara K, Lee KH and Okano M: Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation. Chem Pharm Bull (Tokyo). 45:675–677. 1997. View Article : Google Scholar : PubMed/NCBI
17	Wang Y, Wang WJ, Su C, Zhang DM, Xu LP, He RR, Wang L, Zhang J, Zhang XQ and Ye WC: Cytotoxic quassinoids from Ailanthus altissima. Bioorg Med Chem Lett. 23:654–657. 2013. View Article : Google Scholar : PubMed/NCBI
18	Okunade AL, Bikoff RE, Casper SJ, Oksman A, Goldberg DE and Lewis WH: Antiplasmodial activity of extracts and quassinoids isolated from seedlings of Ailanthus altissima (Simaroubaceae). Phytother Res. 17:675–677. 2003. View Article : Google Scholar : PubMed/NCBI
19	Kundu P and Laskar S: A brief resume on the genus Ailanthus: chemical and pharmacological aspects. Phytochem Rev. 9:379–412. 2010. View Article : Google Scholar
20	Rosati A, Quarantam E, Ammirante M, Turco MC, Leone A and De Feo V: Quassinoids can induce mitochondrial membrane depolarisation and caspase 3 activation in human cells. Cell Death Differ. 11 Suppl 2:S216–S218. 2004. View Article : Google Scholar : PubMed/NCBI
21	Casinovi CG, Ceccherelli P, Grandolini G and Bellavita V: On the structure of ailanthone. Tetrahedron Lett. 5:3991–3997. 1964. View Article : Google Scholar
22	Bishayee A, Háznagy Radnai E, Mbimba T, Sipos P, Morazzoni P, Darvesh AS, Bhatia D and Hohmann J: Anthocyaninrich black current extract suppresses the growth of human hepatocellular carcinoma cells. Nat Pred Commun. 5:1613–1618. 2010.
23	Kim MJ, Kim YJ, Park HJ, Chung JH, Leem KH and Kim HK: Apoptotic effect of red wine polyphenols on human colon cancer SNU-C4cells. Food Chem Toxicol. 44:898–902. 2006. View Article : Google Scholar : PubMed/NCBI
24	Lu YJ, Xu Q, Chen L, Zuo Y, Liu S, Hu Y, Li X, Li Y and Zhao X: Expression of semaphorin 6D and its receptor plexin-A1 in gastric cancer and their association with tumor angiogenesis. Oncology. 12:3967–3974. 2016.
25	Moysich KB, Beehler GP, Zirpoli G, Choi JY and Baker JA: Use of common medications and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 7:1564–1595. 2008. View Article : Google Scholar
26	Kim DW, Hong GH, Lee HH, Choi SH, Chun BG, Won CK, Hwang IK and Won MH: Effect of colloidal silver against the cytotoxicity of hydrogen peroxide and naphthazarin on primary cultured cortical astrocytes. Int J Neurosci. 117:387–400. 2007. View Article : Google Scholar : PubMed/NCBI
27	Duan JA, Su SL and Qian DW: Approaches and advances in the resources chemistry of Chinese medicinal material. Chin J Nat Med. 7:333–340. 2009. View Article : Google Scholar
28	Zhuo Z, Hu J, Yang X, Chen M, Lei X, Deng L, Yao N, Peng Q, Chen Z, Ye W and Zhang D: Ailanthone inhibits Huh7 cancer cell growth via cell cycle arrest and apoptosis in vitro and in vivo. Sci Rep. 5:161852015. View Article : Google Scholar : PubMed/NCBI
29	James BR and Griffith TS: Activation of systemic antitumor immunity via TRAIL-induced apoptosis. OncoImmunology. 17:1178–1180. 2012. View Article : Google Scholar
30	Chen M, Xu XYX D, et al: Inhibiting Bcl-2 gene expression enhance radiosensitivity of non-small cell lung cancer NCI-H460 cells. China Oncology. 20:641–5. 2010.
31	Bai X, Che F, Li J, Ma Y, Zhou Y, Zhai J and Meng L: Effects of adenovirus-mediated p16 and p53 genes transfer on apoptosis and cell cycle of lung carcinoma cells. Zhonghua Bing Li Xue Za Zhi. 29:354–358. 2000.(In Chinese). PubMed/NCBI
32	Zhang Z, Leonard SS, Huang C, Vallyathan V, Castranova V and Shi X: Role of reactive oxygen species and MAPKs in vanadate-induced G(2)/M phase arrest. Free Radic Biol Med. 34:1333–1042. 2003. View Article : Google Scholar : PubMed/NCBI
33	Porter AG and Jänicke RU: Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999. View Article : Google Scholar : PubMed/NCBI
34	Alvarez S, Drane P, Meiller A, Bras M, Deguin-Chambon V, Bouvard V and May E: A comprehens ive s tudy of p53 transcriptional activity in thymus and spleen of gamma irradiated mouse: High sens itivity of genes involved in the two main apoptotic pathways. Int J Radiat Biol. 82:761–770. 2006. View Article : Google Scholar : PubMed/NCBI
35	Raisova M, Hossini AM, Eberle J, Riebeling C, Wieder T, Sturm I, Daniel PT, Orfanos CE and Geilen CC: The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis. J Invest Dermatol. 117:333–340. 2001. View Article : Google Scholar : PubMed/NCBI
36	Samarghandian S, Nezhad MA and Mohammadi G: Role of caspases, Bax and Bcl-2 in chrysin-induced apoptosis in the A549 human lung adenocarcinoma epithelial cells. Anticancer Agents Med Chem. 14:901–909. 2014. View Article : Google Scholar : PubMed/NCBI
37	Wong KK, Engelman JA and Cantley LC: Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev. 20:87–90. 2010. View Article : Google Scholar : PubMed/NCBI
38	Rao E, Jiang C, Ji M, Huang X, Iqbal J, Lenz G, Wright G, Staudt LM, Zhao Y, McKeithan TW, et al: The miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activation. Leukemia. 26:1064–1072. 2012. View Article : Google Scholar : PubMed/NCBI
39	Markman B, Dienstmann R and Tabernero J: Targeting the PI3K/Akt/mTOR pathway-beyond rapalogs. Oncotarget. 1:530–543. 2010.PubMed/NCBI
40	Neri LM, Cani A, Martelli AM, Simioni C, Junghanss C, Tabellini G, Ricci F, Tazzari PL, Pagliaro P, McCubrey JA and Capitani S: Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential. Leukemia. 28:739–748. 2014. View Article : Google Scholar : PubMed/NCBI
41	Slomovitz BM and Coleman RL: The PI3K/AKT/mTOR pathway as a therapeutic target in endometrial cancer. Clin Cancer Res. 18:5856–5864. 2012. View Article : Google Scholar : PubMed/NCBI